Evidence map›Paper›PMID 36844144›Full record

ReviewWorld journal of gastroenterology2023

Contributions of the receptor for advanced glycation end products axis activation in gastric cancer.

Armando Rojas, Cristian Lindner, Iván Schneider, Ileana González, Miguel Angel Morales

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of gastroenterology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Circulating Proteins as Diagnostic Markers in Gastric Cancer.International journal of molecular sciences · 2023
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Armando RojasBiomedical Research Laboratories, Medicine Faculty, Catholic University of Maule, Talca 34600000, Chile. arojasr@ucm.cl.
Cristian LindnerMedicine Faculty, Catholic University of Maule, Talca 34600000, Chile.
Iván SchneiderMedicine Faculty, Catholic University of Maule, Talca 34600000, Chile.
Ileana GonzálezBiomedical Research Laboratories, Medicine Faculty, Catholic University of Maule, Talca 34600000, Chile.
Miguel Angel MoralesMolecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, University of Chile, Santiago 8320000, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Compelling shreds of evidence derived from both clinical and experimental research have demonstrated the crucial contribution of receptor for advanced glycation end products (RAGE) axis activation in the development of neoplasms, including gastric cancer (GC). This new actor in tumor biology plays an important role in the onset of a crucial and long-lasting inflammatory milieu, not only by supporting phenotypic changes favoring growth and dissemination of tumor cells, but also by functioning as a pattern-recognition receptor in the inflammatory response to

Indexed as

Helicobacter InfectionsHelicobacter pyloriStomach NeoplasmsGlycation End Products, AdvancedHumansReceptor for Advanced Glycation End ProductsReceptors, Pattern RecognitionGlycation End Products, AdvancedReceptor for Advanced Glycation End ProductsReceptors, Pattern RecognitionAdvanced glycation end-productsAlarminsChronic inflammationGastric cancerHelicobacter pyloriReceptor of advanced glycation end-products

Identifiers

PMID36844144
PMCPMC9950863

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.